The National Human Rights Committee (NHRC) will organise the Fourth National Human Rights Forum on January 20 and 21, 2026, under the ...
Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...
Vertical integration for CDMOs in manufacturing ADCs offers an opportunity to reduce costs and create a more resilient supply ...
The Biden administration on April 21 shared a formal plan with Congress to address the nation’s addiction and drug overdose crisis. 1. President Joe Biden’s plan aims to address two main causes of the ...
Antibody drugs such as monoclonal antibodies (mAb), bispecific antibodies, antibody-drug conjugates (ADCs), and nanobodies garnered increased interest in research and development circles. Sino ...
Antibody-drug conjugates (ADCs) hold great promise as targeted cancer therapeutics. But their complex structure poses significant development and safety challenges for biopharma. In this GEN webinar, ...
As healthcare costs continue to rise, businesses face increasing pressure to balance comprehensive benefits with financial sustainability. One of the most significant challenges is the escalating cost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback